Literature DB >> 12456794

Yoked complexes of human choriogonadotropin and the lutropin receptor: evidence that monomeric individual subunits are inactive.

Prema Narayan1, Judy Gray, David Puett.   

Abstract

Human choriogonadotropin (hCG) contains an alpha-subunit, common to other members of the glycoprotein hormone family, and a unique beta-subunit that determines hormone specificity. It is generally thought that heterodimer formation is obligatory for full hormonal activity, although other studies have indicated that individual subunits and homodimeric hCGbeta were capable of low affinity binding to the LH receptor (LHR) and subsequent activation. Previously, we constructed two yoked hormone (hCG)-LHR complexes, where the two hormone subunits and the heptahelical receptor were engineered to form single polypeptide chains, i.e. N-beta-alpha-LHR-C and N-alpha-beta-LHR-C. Expression of both complexes led to constitutive stimulation of cAMP production. In the present study, we investigated whether the human alpha-subunit and hCGbeta can act as functional agonists when covalently attached to or coexpressed with the LH receptor. Our initial results showed that hCGbeta, but not alpha, was able to activate LHR with an increase in intracellular cAMP in human embryonic kidney 293 cells but not in Chinese hamster ovary or COS-7 cells. Further examination of this apparent cell-specific agonist activity of hCGbeta revealed that low levels of endogenous alpha-subunit were expressed in human embryonic kidney 293 cells, thus enabling sufficient amounts of active heterodimer to form with the transfected hCGbeta to activate LHR. The studies in Chinese hamster ovary and COS-7 cells clearly demonstrate that, even under experimental conditions where hormone-receptor interactions are maximized, individual subunits of hCG can not act as functional agonists, at least in their monomeric form.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12456794     DOI: 10.1210/me.2002-0208

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  7 in total

1.  Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patients.

Authors:  Michael A Morse; Robert Chapman; John Powderly; Kimberly Blackwell; Tibor Keler; Jennifer Green; Renee Riggs; Li-Zhen He; Venky Ramakrishna; Laura Vitale; Biwei Zhao; Stephen A Butler; Amy Hobeika; Takuya Osada; Thomas Davis; Timothy Clay; H Kim Lyerly
Journal:  Clin Cancer Res       Date:  2011-06-01       Impact factor: 12.531

Review 2.  The luteinizing hormone receptor: insights into structure-function relationships and hormone-receptor-mediated changes in gene expression in ovarian cancer cells.

Authors:  David Puett; Krassimira Angelova; Marcelo Rocha da Costa; Susanne W Warrenfeltz; Francesca Fanelli
Journal:  Mol Cell Endocrinol       Date:  2010-05-02       Impact factor: 4.102

3.  Human alpha-subunit analogs act as partial agonists to the thyroid-stimulating hormone receptor: differential effects of free and yoked subunits.

Authors:  Krassimira Angelova; Valerie Fremont; Renita Jain; Meng Zhang; David Puett; Prema Narayan; Mariusz W Szkudlinski
Journal:  Endocrine       Date:  2004-06       Impact factor: 3.633

4.  Precocious puberty and Leydig cell hyperplasia in male mice with a gain of function mutation in the LH receptor gene.

Authors:  Stacey R McGee; Prema Narayan
Journal:  Endocrinology       Date:  2013-07-16       Impact factor: 4.736

5.  An autopsy case of primary mixed choriocarcinoma and mature teratoma located in the thymic region associated with elevated human chorionic gonadotropin levels and characteristic testicular changes.

Authors:  Takashi Yuri; Naoto Shimano; Yasuhiro Ohashi; Katsuaki Miki; Reiko Tsukamoto; Airo Tsubura
Journal:  Med Mol Morphol       Date:  2006-03       Impact factor: 2.070

Review 6.  Animal models for aberrations of gonadotropin action.

Authors:  Hellevi Peltoketo; Fu-Ping Zhang; Susana B Rulli
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

Review 7.  Genetic Models for the Study of Luteinizing Hormone Receptor Function.

Authors:  Prema Narayan
Journal:  Front Endocrinol (Lausanne)       Date:  2015-09-29       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.